Get started
Author

S. Catot

Brain metastases from lung cancer responding to erlotinib: the importance ofEGFRmutation
2010 · R. Porta, J.M. Sánchez-Torres, et al. · European Respiratory Journal · 323
PDF
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies
2014 · T. Moran, J. Wei, et al. · Annals of Oncology · 32
Mitotic checkpoint gene CHFR methylation in pretreatment serum DNA of docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (p)
2006 · D. Isla, F. Salazar, et al. · Journal of Clinical Oncology · 2
P-561 14-3-3 sigma (σ) methylation (M) in pre-treatment serum DNAof cisplatin (cis)/gemcitabine (gem)-treated non-small-cell lung cancer (NSCLC)
2005 · J. Ramirez, S. Catot, et al. · Lung Cancer · 2
OA01.02 The Mirror Study: Tumor Microenvironment (TME) in Patients With Non-Small Cell Lung Cancer Exposed to Indoor Radon +/- Tobacco Smoke
2025 · M. Garcia de Herreros, M. Jiménez, et al. · Journal of Thoracic Oncology · 1
Primary Malignant Pericardial Mesothelioma
2012 · Jesus Montesinos, Slvia Catot, et al. · InTech eBooks · 1
Predictive value of single nucleotide polymorphisms (SNPs) in DNA repair genes in non-selected advanced colorectal cancer (CRC) patients (p) treated with oxaliplatin (OXA) plus 5-Fluorouracil (5-FU) first-line chemotherapy (CT)
2004 · E. Martinez-Balibrea, J. L. Manzano, et al. · Journal of Clinical Oncology · 1
MO06.07: The DUMAS Trial, Neo-Adjuvant Immunotherapy for Pancoast Tumors
2026 · M. Provencio, A.L. Ortega, et al. · Journal of Thoracic Oncology
P2.178: Accelerating NGS Workflows in Advanced NSCLC: The Predictive Value of Serum Tumor Markers for Actionable Genomic Alterations
2026 · J. Trape, S. Catot, et al. · Journal of Thoracic Oncology
P2.386: MERLIN, Tarlatamab Treatment for Limited Small Cell Lung Cancer in Patients in Maintenance: A Phase II Clinical Trial
2026 · M. Dómine, B. Campos, et al. · Journal of Thoracic Oncology
P3.12.30 Histological Transformation as Resistance Mechanism in NSCLC: A Multicenter Study Exploring Clinico-Pathological and Molecular Features
2025 · S. Torresan, C. Salva de Torres, et al. · Journal of Thoracic Oncology
748P Real-world-data (RWD) on platinum (Pt)-based chemotherapy (CT) after PARP inhibitors (PARPi) in high-grade serous (or endometrioid) ovarian cancer (HGSEOC)
2021 · M. Romeo Marin, M. Gil-Martin, et al. · Annals of Oncology
PDF
MA22.05 Assessment of Gender Differences in the Psychosocial and Economic Impact on Patients with Stage IV Non-Small Cell Lung Cancer
2019 · P. Garrido, R. Garcia Campelo, et al. · Journal of Thoracic Oncology
PDF
MA08.09 Results of Trimodality Therapy for Patients with cN2 Lung Cancer Diagnosed by Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA)
2019 · S. Call, C. Obiols, et al. · Journal of Thoracic Oncology
Tumor markers in pleural fluid as prognostic factor in patient with lung cancer and pleural effusion
2019 · J. Trapé, L. Sugrañes, et al. · Clinica Chimica Acta
Circulating tumor cell analysis in patients with advanced non-small cell lung cancer treated with biweekly gemcitabine and docetaxel.
2010 · O. Juan Vidal, T. Fleitas, et al. · Journal of Clinical Oncology
Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in non-small cell lung cancer (NSCLC) patients with ECOG performance status 2.
2010 · V. Giner, O. Juan Vidal, et al. · Journal of Clinical Oncology
Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
2010 · C. Llorca, G. Esquerdo, et al. · Journal of Clinical Oncology
9000 Mutations of EGFR (mEGFR) in tumour tissue and serum DNA from stage IV non-small-cell lung cancer (NSCLC) patients (p) prospectively treated with erlotinib
2009 · R. Rosell, B. Massuti, et al. · European Journal of Cancer Supplements
9031 Lung cancer in women: the Spanish female-specific database WORLD 07
2009 · M. Majem, M. Domine, et al. · European Journal of Cancer Supplements
8047 Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy (IV/IP) in optimally debulked stage III ovarian cancer patients: A GEICO Study
2009 · A. Oaknin, D. Roda, et al. · European Journal of Cancer Supplements
14-3-3 σ (σ) methylation (M) in pre-treatment serum DNA of cisplatin (cis)/gemcitabine (gem)-treated non-small-cell lung cancer (NSCLC)
2005 · J. L. Ramirez, R. Rosell, et al. · Journal of Clinical Oncology
Works count: 22
Citation count: 362
H-index: 2
I10-index: 2
Year
Topic
Type